Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 5—May 2011

Dengue Virus Serotype 4, Roraima State, Brazil

On This Page
citations of this article
EID Journal Metrics on Scopus

Cite This Article


Thumbnail of A) Boa Vista, Roraima State, Brazil, showing the districts where dengue virus type 4 (DENV-4) was isolated. 1, Liberdade; 2, Buritis; 3, Cauamé; 4, Santa Tereza; 5, Cidade Satélite; 6, Dr. Silvio Leite; 7, Joquel Clube; 8, Sen. Hélio Campos. B) Phylogenetic analysis of the DENV-4 envelope gene sequences (in boldface) constructed by using the neighbor-joining method, showing the cluster formed by Boa Vista and Venenzuela DENV-4 genotype I strains. Bootstrap values were set for 1,000

Figure. A) Boa Vista, Roraima State, Brazil, showing the districts where dengue virus type 4 (DENV-4) was isolated. 1, Liberdade; 2, Buritis; 3, Cauamé; 4, Santa Tereza; 5, Cidade Satélite; 6, Dr....

To the Editor: In July 2010, dengue virus serotype 4 (DENV-4) reemerged in Boa Vista, the capital of Roraima State, in northern Brazil (Figure, panel A), after an absence of 28 years (1). Cases were identified during late June in the municipalities of Boa Vista and Cantá. For all patients, the clinical course of disease was classic, and all recovered uneventfully. The most commonly reported signs and symptoms were fever, headache, chills, muscle and joint pains, rash, nausea and vomiting, and retro-ocular pain. Patient ages were 11–51 years (median 31 years); 5 patients were male.

Because of the clinical picture, dengue was suspected, and serum samples were collected and sent to Instituto Evandro Chagas for virus isolation. Of 10 DENV strains recovered, 9 were isolated into C6/36 cell samples as described elsewhere (2). Cytopathic effects were observed on days 5–7 postinfection, and virus isolation was confirmed by use of indirect immunofluorescent assay (3). Molecular approaches led to diagnosis of 10 cases. Viral RNA was recovered from infected cells in the supernatant by using a QIAquick viral RNA extraction kit (QIAGEN, Valencia, CA, USA); genome amplification was performed by using a 1-step reverse transcription–PCR (RT-PCR) (4) and 2 set of oligonucleotides designed to amplify the entire N gene in overlapping PCR products. PCR amplification was performed on 5 DENV strains, and the envelope gene (1,425 bp) was completely sequenced by the dideoxinucleotide terminator method for 3 strains (5) by using the same set of oligonucleotides as for the RT-PCR amplification.

Phylogenetic analysis was performed by using the neighbor-joining method (6) and homologous sequences of different DENV-4 strains isolated in Central and South America (7,8). The Asian genotype II strains (Thailand 1978-U18441 and Thailand 1985-AY780644) were used as outgroups to give confidence to phylogenetic groupings. Phylogenetically, the DENV-4 strains grouped in genotype I and clustered with Venezuelan strains isolated from 2004 through 2007 (Brazil/Venezuela group) and were distantly related to strains isolated in Venezuela from 1998 through 2000. This result indicates that the current DENV-4 strains isolated in Roraima State were reintroduced to Brazil through Venezuela, where DENV-4 has circulated since the 1980s (1). This result also excludes the possibility that Asian genotypes previously circulated in Brazil. The DENV-4 strains isolated from patients in Roraima State in 2010 were genetically distinct from DENV-4 strains isolated in the 1980s (Figure, panel B).

During the 2010 outbreak, cocirculation of DENV-1 and DENV-2 in addition to DENV-4 was demonstrated by virus isolation (68 strains) and RT-PCR amplification (genome detection in 39 strains). The municipality of Boa Vista, which has ≈266,901 inhabitants, reported 5,243 dengue cases (3,936 dengue fever, 259 severe dengue or dengue hemorrhagic fever) in 2010 (epidemiologic week 37), many of them diagnosed by serologic testing (9). These numbers represent an increase of 154% over the 2,066 cases reported in 2009 (10).

DENV-4 had been introduced to Brazil through Boa Vista before the reemergence reported here; in 1982, DENV-1 and DENV-4 were described in Brazil, and a serologic survey estimated 11,000 dengue infections (1). After that outbreak, DENV-4 was eradicated and not again detected until the episode reported here. To monitor the circulation of DENV-4 in Roraima and other Brazilian states through the present date (epidemiologic week 48), strong serologic and virologic surveillance have been conducted; cases of this serotype have not been recognized outside Roraima State. As a preventive measure in Boa Vista, a total of 10,358 dwellings were visited and 18,305 larval Aedes aegypti mosquito foci were eliminated by spraying of mosquito adulticide. Nonetheless, as summer approaches in Brazil, a heavy rainy season is expected, and DENV-4 is a candidate to become a serious threat in the country. Therefore, the Ministry of Health has prepared a plan to investigate DENV-4 circulation; it calls for early detection of disease and adoption of control measures to avoid or minimize spread of this dengue serotype throughout the country.


José Gomes Temporão, Gerson Oliveira Penna, Eduardo Hage Carmo, Giovanini Evelim Coelho, Raimunda do Socorro Silva Azevedo, Márcio Roberto Teixeira Nunes, and Pedro F.C. VasconcelosComments to Author 

Author affiliations: Author affiliations: Ministry of Health Brasília, Brasilia, Brazil (J.G. Temporão, G.O. Penna); University of Brasília, Brasilia (G.O. Penna); Secretariat of Health Surveillance, Brasilia (E.H. Carmo, G.E. Coelho); Evandro Chagas Institute, Ananindeua, Brazil (R. do Socorro Silva Azevedo, M.R.T. Nunes, P.F. da Costa Vasconcelos)



  1. Osanai  CH, Travassos da Rosa  AP, Tang  AT, do Amaral  RS, Passos  AD, Tauil  PL. Dengue outbreak in Boa Vista, Roraima [in Portuguese]. Rev Inst Med Trop Sao Paulo. 1983;25:534.PubMed
  2. Beaty  BJ, Calisher  CH, Shope  RE. Arboviruses. In: Lennette EH, Lennette DA, Lennette ET, editors. Diagnostic procedures for viral, rickettsial, and chlamydial infections, 7th ed. Washington: American Public Health Association; 1995. p. 189–212.
  3. Endy  TP, Nisalak  A, Vaughn  DW. Diagnosis of dengue virus infections. In: Halstead SB, editor. Dengue. London: Imperial College Press; 2008. p. 327–60.
  4. Lanciotti  RS, Calisher  CH, Gubler  DJ, Chang  G-J, Vorndam  V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase–polymerase chain reaction. J Clin Microbiol. 1992;30:54551.PubMed
  5. Sanger  F, Nicklen  S, Coulson  AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A.  1977;74:5463–7.
  6. Saitou  N, Nei  M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:40625.PubMed
  7. Dussart  P, Lavergne  A, Lagathu  G, Lacoste  V, Martial  J, Morvan  J, Reemergence of dengue virus type 4, French Antilles and French Guiana, 2004–2005. Emerg Infect Dis. 2006;12:174851.PubMed
  8. Forshey  BM, Morrison  AC, Cruz  C, Rocha  C, Vilcarromero  S, Guevara  C, Dengue virus serotype 4, northeastern Peru, 2008. Emerg Infect Dis. 2009;15:18158.PubMed
  9. Nunes  MR, Nunes Neto  JP, Casseb  SM, Nunes  KN, Martins  LC, Rodrigues  SG, Evaluation of an immunoglobulin M–specific capture enzyme-linked immunosorbent assay for rapid diagnosis of dengue infection. J Virol Methods. 2011;17113–20.
  10. Secretariat of Health Surveillance. Dengue reported cases, 2010 [in Portuguese] [cited 2010 Oct 4].




Cite This Article

DOI: 10.3201/eid1705.101681

Related Links


Table of Contents – Volume 17, Number 5—May 2011


Please use the form below to submit correspondence to the authors or contact them at the following address:

Pedro Fernando da Costa Vasconcelos, Instituto Evandro Chagas, National Institute for Viral Hemorrhagic Fevers, Department of Arbovirology and Hemorrhagic Fevers, Rodovia BR-316, KM 07, 67030-000, Ananindeua, Brazil

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.


Page created: August 14, 2011
Page updated: August 14, 2011
Page reviewed: August 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.